3-year follow-up study of secukinumab treatment in patients with active Ankylosing Spondylitis
An extension study to evaluate the sustainability of clinical benefits, safety and tolerability of secukinumab in patients with active Ankylosing Spondylitis An extension study to evaluate the sustainability of clinical benefits, safety and tolerability of s ...
United States;Taiwan;Turkey;Russian Federation;United Kingdom;Italy;France;Mexico;Canada;Belgium;Peru;Bulgaria;Germany;Netherlands United States;Taiwan;Turkey;Russian Federation;United Kingdom;Italy;France;Mexico;Canada;Belgium;Per ...